Reported covered position: Strategic Policy Advisor to the Executive Vice President
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
New Era of Preventing End-Stage Kidney Disease Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · third_quarter · Q3
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance
Source: Senate LDA
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Diabetes Foot Health Access and Modernization Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
H–1Bs for Physicians and the Healthcare Workforce Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Provider Reimbursement Stability Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
KIDNEY Remote Monitoring Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
KIDNEY Remote Monitoring Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Answering the Call Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Answering the Call Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Improving Home Dialysis Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Improving Home Dialysis Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Kidney Disease Education Access Expansion Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Kidney Disease Education Access Expansion Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Diabetes Foot Health Access and Modernization Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Organ Donation Referral Improvement Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Removing Burdens From Organ Donation Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
CONNECT for Health Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
CONNECT for Health Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
OPTN Fee Collection Authority Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Give Kids a Chance Act of 2024
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · second_quarter · Q2
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · first_quarter · Q1
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · fourth_quarter · Q4
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · second_quarter · Q2
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ -One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · first_quarter · Q1
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · fourth_quarter · Q4
FY 25 Congressional appropriations: -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · third_quarter · Q3
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · second_quarter · Q2
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · first_quarter · Q1
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · fourth_quarter · Q4
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · third_quarter · Q3
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · second_quarter · Q2
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · fourth_quarter · Q4
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enable access to telehealth by removing home and originating site restrictions in statute, as in the CONNECT for Health Act (H.R. 2903/S. 1512)
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general, including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · third_quarter · Q3
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general, including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million
-Access to COVID-19 vaccines and boosters for people with kidney diseases, including transplantation and dialysis
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enable access to telehealth by removing home and originating site restrictions in statute, as in the CONNECT for Health Act (H.R. 2903/S. 1512)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · second_quarter · Q2
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · 1A
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · Q1
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · fourth_quarter · Q4
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of anti-kickback statutes Provide education regarding ASN's support for HHS proposed rule regarding organ procurement organization reform (42 CFR 486 or CMS-3380-P)
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · third_quarter · Q3
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · second_quarter · Q2
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of antikickback statutes
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · fourth_quarter · Q4
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · third_quarter · Q3
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · second_quarter · Q2
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (forthcoming legislation) Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX. Urged support for KidneyX program more generally.
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Need for a pathway to add new devices to the ESRD payment bundle Challenges with Organ Procurement Organization data integrity and evaluation framework
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million). Urged Congressional support for KidneyX program more generally. Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · second_quarter · Q2
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Supported allowing veterans in the VA healthcare system to receive transplants at non-VA facilities (VCTA bill and VICTOR Bill, ultimately passed as MISSION Act, S. 2372).
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · first_quarter · Q1
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Supported allowing veterans in the VA healthcare system to receive transplants at non-VA facilities (VCTA bill, draft form)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with proposed Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions to limit dialysis more than 3 times per week Proposed new care delivery models for comprehensive kidney care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Promoted ASN Guiding Principles for Health Reform, advocated against enactment of ACA repeal bill Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with proposed Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions to limit dialysis more than 3 times per week
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · second_quarter · Q2
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Promoted ASN Guiding Principles for Health Reform, advocated against enactment of ACA repeal bill Supported several telehealth bills to permit home dialysis patients to interface with nephrologist from home (H.R. 3178, H.R.2550, S.870)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · first_quarter · Q1
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Discussed need for/opportunities to advance kidney research and innovation, including kidney disease prize competition Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2016 · fourth_quarter · Q4
Supported legislation to permit patients with ESRD enrolling in Medicare Advantage Plans (H.R. 5659) Supported legislation to expand telehealth access S.2484 (CONNECT Act) Supported HR1130/S598 (comprehensive kidney care legislation)
Discussed importance of investments in kidney care research at NIH, VA and encouraged cross-Institute Center collaboration on kidney research Discussed need for/opportunities to advance kidney research and innovation, including kidney disease prize competition Discussed potential outcomes of GAO report on kidney research
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA), White House Office
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2016 · third_quarter · Q3
Discussed legislation concerning care delivery models for Medicare beneficiaries with kidney disease (including HR 5506/S 3090) Supported legislation to permit patients with ESRD enrolling in Medicare Advantage Plans (H.R. 5659) Discussed transplantation policy in general Implementation of 2015 TAA/TPA legislation related to AKI care Supported HR1130/S598 (comprehensive kidney care legislation)
Advocacy in support of appropriations for federal research programs, particularly NIH, VA, and AHRQ, in the FY2017 budget. Discussed importance of investments in kidney care research at NIH, VA and encouraged cross-Institute Center collaboration on kidney research Discussed need for/opportunities to advance kidney research and innovation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA), White House Office
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2016 · second_quarter · 2A
Advocacy in support of appropriations for federal research programs, particularly NIH, VA, and AHRQ, in the FY2017 budget. Advocacy for the 21st Century Cures Act Discussed importance of investments in kidney care research at NIH, VA, OMB
Advocacy for CONNECT Act (S. 2484/HR. 4442), particularly home as originating site for home dialysis patients Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with kidney disease (including HR 5506/S 3090) Discussed transplantation policy in general Implementation of 2015 TAA/TPA legislation related to AKI care Support for HR1130/S598 (comprehensive kidney care legislation)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2016 · second_quarter · Q2
Advocacy in support of appropriations for federal research programs, particularly NIH, VA, and AHRQ, in the FY2017 budget. Advocacy for the 21st Century Cures Act Discussed importance of investments in kidney care research at NIH, VA, OMB
Advocacy for the 21st Century Cures Act Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with kidney disease (including HR 5506/S 3090) Discussed transplantation policy in general Implementation of 2015 TAA/TPA legislation related to AKI care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2016 · first_quarter · Q1
Advocacy for the 21st Century Cures Act Advocated for introduction of CONNECT Act HR4442/S2484 (telemedicine in Medicare program) Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with ESRD Discussed transplantation policy generally
Advocacy in support of appropriations for federal research programs, particularly NIH, VA, and AHRQ, in the FY2017 budget. Advocacy for the 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2015 · fourth_quarter · Q4
Advocacy on issues and legislation in support of prize competitions. Advocacy in support of increased funding for federal research programs, particularly NIH, VA, and AHRQ, in the FY2016 budget.
Advocated for support for HR1130/S598, the CKD Improvement in Research and Treatment Act of 2015 in the House and Senate. Voiced support for concept of accelerating cures for patients in 21st Century Cures in the Senate Voiced support for expanded telemedicine in Medicare program in the House (Medicare Telehealth Parity Act of 2015) and discussed drafting companion legislation in Senate Advocated for the introduction of the Living Donor Protection Act (kidney transplantation policy)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2015 · third_quarter · Q3
Advocated for support for HR1130/S598, the CKD Improvement in Research and Treatment Act of 2015 in the House and Senate. Voiced support for concept of accelerating cures for patients in 21st Century Cures in the House and Senate Voiced support for expanded telemedicine in Medicare program in the House (Medicare Telehealth Parity Act of 2015) Advocated for the introduction of the Living Donor Protection Act (kidney transplantation policy)
Advocacy on issues and legislation in support of prize competitions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2015 · second_quarter · Q2
Advocacy on issues and legislation in support of prize competitions.
Advocated for support for HR1130/S598, the CKD Improvement in Research and Treatment Act of 2015 in the House and Senate. Voiced support for concept of accelerating cures for patients in 21st Century Cures in the House and Senate Voiced support for expanded telemedicine in Medicare program in the House (Medicare Telehealth Parity Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2015 · first_quarter · Q1
Discussed interest in a potential prize competition in the kidney space
Advocated for support for HR1130/S598, the CKD Improvement in Research and Treatment Act of 2015 in the House and Senate. Voiced support for concept of accelerating cures for patients in 21st Century Cures in the House Voiced support for expanded telemedicine in Medicare program in the House Met with DARPA and PCORI to discuss kidney research opportunities Met with CMS to discuss
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense Advanced Research Projects Agency (DARPA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2014 · fourth_quarter · Q4
Advocate for the development of an X-Prize in kidney treatment and innovation. Work to develop analytical tools for Congress to better understand the need for innovation in kidney care to improve treatment outcomes and lower costs. Advocate support for HR 4814 and for telehealth expansion.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2014 · third_quarter · Q3
Advocated in support of HR 4814, the Chronic Kidney Disease Treatment and Innovation Act of 2014
Advocate for the development of a prize competition in kidney treatment and innovation. Worked to develop analytical tools for Congress to better understand the need for innovation in kidney care to improve treatment outcomes and lower costs.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2014 · second_quarter · Q2
Advocating for federal appropriations for kidney research, specifically for the VA and the NIH.
Advocated support for HR 4814, Comprehensive CKD Research and Innovation Act of 2014
Highlighting the value of prize competitions and investment in research, including certain provisions in the FIRST Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Aeronautics & Space Administration (NASA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2014 · first_quarter · Q1
Highlighting the value of prize competitions and investment in research, including certain provisions in the FIRST Act.
Advocating for federal appropriations for kidney research, specifically for the VA and the NIH.
Advocating support for the Comprehensive Immunosuppressive Drug Coverage Act (S. 323/HR 1428).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2013 · first_quarter · 1A
Advocacy for two transplant-related bills (Comprehensive Immunosuppressive Drug Coverage Act of 2013 and HIV Organ Policy Equity Act).
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2013 · fourth_quarter · Q4
Advocated in support of transplant-related legislation HR 698/S330 and HR 1428/S323.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2013 · third_quarter · Q3
Advocated for Medicare ESRD Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2013 · second_quarter · Q2
Advocated for apporpriations for kidney research funding at NIH and VA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2013 · first_quarter · Q1
Advocacy for two transplant-related bills (Comprehensive Immunosuppressive Drug Coverage Act of 2013 and HIV Organ Policy Equity Act).
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2012 · fourth_quarter · Q4
Affordable Care Act implemtation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2012 · third_quarter · Q3
Advocating for sustained funding for the National Institutes of Health, specifically, for kidney research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2012 · second_quarter · Q2
Advocacy on kidney care issues and the ASN membership
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2012 · first_quarter · Q1
Advocated in the U.S. House of Representatives and in the U.S. Senate for robust, sustained appropriations for the NIH. ASN also Signed coalition letters to Congressional leaders and LHHS Subcommittee members regarding funding requests for the Prevention and Public Health Fund and HRSA.
Discussed interest in advancing regulatory science and improving patient safety related to kidney health. Responded to request for comment regarding strategies to reduce sodium intake.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2011 · fourth_quarter · Q4
Discussed NIH budget and grant funding allocation with Institute Directors and conducted congressional office visits to discuss NIH research funding.
LHHS Appropriations - Health-related funding and medical research.
Provided verbal comments and answered questions related to ESRD coverage, especially regarding immunosuppressive drug coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2011 · third_quarter · Q3
LHHS Appropriations - FY 2012 Signed coalition letters to Congressional leaders and LHHS Subcommittee members Sent letter to Joint Committee on Deficit Reduction
Provided written comments to and answered questions for the Medicare ESRD Program related to the proposed rule on the ESRD prospective payment system for 2012 and the quality incentive program for 2013 and 2014.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US -Expediting priority access to COVID-19 vaccines for people who are on dialysis and the staff and clinicians who care for them in dialysis units
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of anti-kickback statutes Provide education regarding ASN's support for HHS proposed rule regarding organ procurement organization reform (42 CFR 486 or CMS-3380-P) Opposed proposed rule from ICE that would limit immigration, urging that requested the final rule exclude J-1 clinicians and scientists from the proposal.
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)